ロード中...
Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects
Bcr-Abl acquires its transforming abilitythro ugh its upregulated Abl tyrosine kinase activity. Bcr is a phosphoprotein with a novel serine/threonine kinase activitye ncoded by its first exon. In chronic myelogenous leukemia (CML) cells, Bcr-Abl phosphorylates Bcr on tyrosine residues reducing its k...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2585769/ https://ncbi.nlm.nih.gov/pubmed/17934518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.onc.1210851 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|